Saturday - February 21, 2026

Category Archives: Science

Soft Tissue Sarcoma Clinical Trial Pipeline Gains Momentum: 70+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Soft Tissue Sarcoma Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Soft Tissue Sarcoma pipeline landscape. It covers the Soft Tissue Sarcoma Marketed and Pipeline Drugs profiles, including clinical and nonclinical stage … Continue reading →

Charcot Marie Tooth Clinical Trial Pipeline Accelerates as 10+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Charcot Marie Tooth Disease Pipeline Insight, 2026” report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Charcot Marie Tooth Disease pipeline landscape. It covers the Charcot Marie Tooth pipeline drug profiles, including clinical and nonclinical stage … Continue reading →

Metastatic Colorectal Cancer Clinical Trial Pipeline Shows Potential with Active Contributions from 150+ Key Companies | DelveInsight

DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight 2026” report provides comprehensive insights about 150+ companies and 180+ pipeline drugs in Metastatic Colorectal Cancer pipeline landscape. It covers the Metastatic Colorectal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Oncolytic Virus Cancer Therapy Clinical Trial Pipeline Appears Robust With 120+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Oncolytic Virus Cancer Therapy Pipeline Insight 2026” report provides comprehensive insights about 120+ companies and 125+ pipeline drugs in Oncolytic Virus Cancer Therapy pipeline landscape. It covers the Oncolytic Virus Cancer Therapy pipeline drug profiles, including clinical and non-clinical … Continue reading →

Beyond Binary: Qubic’s Neuraxon 2.0 Introduces a Trinary Architecture for Continuous, Adaptive AI Systems

Fort Lauderdale, Florida – Qubic has just released Neuraxon 2.0, a bio-inspired neural computation framework built on trinary logic and continuous-time processing, proposing an alternative architectural foundation for adaptive artificial intelligence systems. Detailed in a newly published research paper, Neuraxon … Continue reading →

GLP-1 SuperDefender: The Revolutionary Oral Protection Appliance Against “Ozempic Teeth” for Ozempic and Other GLP-1 Medications

Treat Ozempic Teeth using Revolutionary GLP-1 Super Defender – Made by Dentists in Los Angeles, CA, USA Los Angeles, California – Feb 18, 2026 – As medications like Ozempic®, Wegovy®, and Mounjaro® continue to reshape the future of weight management and … Continue reading →

Best GD&T Training Courses: Professional Geometric Dimensioning and Tolerancing Training by Excedify

GD&T Certification Excedify announces its complete GD&T Certification Pathway, a structured, four-level professional training program in Geometric Dimensioning and Tolerancing. The pathway guides engineers from technical drawing fundamentals through GD&T essentials, advanced GD&T applications, and tolerance stack-up analysis. Designed for … Continue reading →

Motor Neuron Disease Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Motor Neuron Disease Pipeline Insight 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Motor Neuron Disease pipeline landscape. It covers the Motor Neuron Disease pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →